Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2,371,778
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
179,153
-
Shares change
-
-174,000
-
Total reported value, excl. options
-
$398,820
-
Value change
-
-$449,714
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$2.23
Significant Holders of Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) as of Q2 2025
13 filings reported holding ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179,153 shares
of 2,371,778 outstanding shares and own 7.6% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (86,666 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (74,711 shares), GEODE CAPITAL MANAGEMENT, LLC (10,161 shares), FNY Investment Advisers, LLC (3,000 shares), SBI Securities Co., Ltd. (2,336 shares), Tower Research Capital LLC (TRC) (1,369 shares), MORGAN STANLEY (378 shares), UBS Group AG (354 shares), RAYMOND JAMES FINANCIAL INC (94 shares), and BlackRock, Inc. (65 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.